Nipah virus is a highly contagious zoonotic virus that causes severe brain infection (encephalitis) and respiratory illness, with a high fatality rate.

How is Nipah virus transmitted to humans?

Nipah virus spreads through contaminated fruits or palm sap from bats, infected animals like pigs, and human-to-human contact via respiratory droplets and body fluids.

What are the early symptoms of Nipah virus infection?

Early symptoms include fever, headache, muscle pain, fatigue, vomiting, and sore throat, followed by neurological signs.

What serious complications can Nipah virus cause?

Severe complications include encephalitis, seizures, coma, acute respiratory distress syndrome (ARDS), multi-organ failure, and death.

What is the incubation period of Nipah virus?

The incubation period usually ranges from 4 to 14 days, but in some cases can extend up to 45 days.

How is Nipah virus diagnosed?

Diagnosis is confirmed using RT-PCR to detect viral RNA in blood, throat swabs, or cerebrospinal fluid, along with antibody tests such as ELISA.

Is there a specific treatment for Nipah virus?

There is no specific approved antiviral treatment; management is mainly supportive, including intensive care, ventilation, seizure control, and hydration.

Are there any experimental drugs for Nipah virus?

Experimental treatments include Ribavirin, monoclonal antibody m102.4, and Remdesivir, though none are officially approved.

What is the fatality rate of Nipah virus?

The case fatality rate ranges from approximately 40% to 75%, depending on outbreak severity and access to medical care.

Can Nipah virus spread from person to person?

Yes, human-to-human transmission can occur through close contact with infected individuals, especially in healthcare or household settings.

What long-term effects can occur in Nipah survivors?

Survivors may experience memory loss, personality changes, chronic fatigue, seizure disorders, and relapsing encephalitis.

Who is at highest risk of Nipah virus infection?

High-risk groups include people consuming raw date palm sap, healthcare workers without protective equipment, caregivers, and residents of outbreak regions.

How can Nipah virus outbreaks be prevented?

Prevention includes avoiding raw palm sap, washing fruits, reducing bat and animal exposure, isolating infected patients, and following infection control measures.

Is there a vaccine available for Nipah virus?

Currently, no approved vaccine exists, but several vaccine candidates are under development and clinical trials.

Why is Nipah virus considered a global health threat?

Nipah virus is considered a priority pathogen due to its high mortality, ability to spread between humans, lack of treatment, and pandemic potential.

Nipah Virus Disease Overview Symptoms Causes Diagnosis Treatment and Prevention

1. Definition

Nipah virus (NiV) is a highly pathogenic zoonotic virus belonging to the Paramyxoviridae family that causes severe encephalitis and acute respiratory illness in humans, with a high case fatality rate (40–75%).

2. Virology & Pathophysiology

Virus type: Negative-sense, single-stranded RNA virus
Natural reservoir: Fruit bats (Pteropus species)
Mechanism of disease:

* Virus enters through respiratory or oral mucosa

* Spreads via bloodstream

* Infects endothelial cells, causing vasculitis

* Leads to brain inflammation (encephalitis) and respiratory damage

* Causes multi-organ failure in severe cases

3. Transmission Routes

Bat → Human (via contaminated fruits or palm sap)
Animal (pigs) → Human
Human → Human (respiratory droplets & close contact)
Exposure to body fluids of infected individuals

4. Incubation Period

4–14 days (can extend up to 45 days)

5. Clinical Features

A. Early Symptoms

Fever
Headache
Myalgia
Fatigue
Sore throat
Vomiting

B. Neurological Manifestations

Confusion
Altered mental status
Seizures
Reduced consciousness
Encephalitis
Coma

C. Respiratory Symptoms

Cough
Shortness of breath
Acute respiratory distress syndrome (ARDS)

D. Severe Complications

Brain edema
Multi-organ failure
Shock
Death

6. Long-Term Sequelae (Survivors)

Memory impairment
Personality changes
Chronic fatigue
Seizure disorders
Relapsing encephalitis months to years later

7. Risk Factors

Consumption of raw date palm sap
Contact with bats or infected animals
Healthcare workers without PPE
Close contact with infected patients
Living in outbreak regions (South Asia)

8. Diagnosis & Investigations

A. Laboratory Confirmation

RT-PCR (Gold Standard) — throat swab, CSF, blood
ELISA — IgM and IgG antibodies
Virus isolation (BSL-4 labs only)

B. Supportive Tests

CBC (may show thrombocytopenia)
Liver function tests
CSF analysis
MRI brain → encephalitis lesions
Chest X-ray/CT → pneumonia or ARDS

9. Differential Diagnoses

Japanese encephalitis
COVID-19
Dengue encephalopathy
Herpes simplex encephalitis
West Nile virus
Bacterial meningitis
Rabies

10. Management & Treatment

No specific approved antiviral therapy. Management is supportive.

A. Supportive Care

ICU monitoring
Oxygen therapy
Mechanical ventilation if respiratory failure
IV fluids and electrolyte balance
Antipyretics and analgesics
Seizure control
Nutritional support

11. Antiviral & Experimental Therapies

Ribavirin

Indication: Experimental use
Mechanism: RNA synthesis inhibition
Dose (Adult): 30 mg/kg loading → 15 mg/kg every 6 hours
Adverse effects: Hemolytic anemia, liver toxicity

Monoclonal Antibody (m102.4)

Experimental neutralizing antibody
Used under compassionate protocols

Remdesivir

Investigational use in some outbreaks

12. Infection Control & Isolation

Strict contact and droplet precautions
PPE for healthcare workers
Patient isolation
Safe disposal of body fluids
Avoid unnecessary exposure

13. Prevention Measures

Public Health Measures

Avoid raw date palm sap
Wash fruits thoroughly
Avoid sick animals
Community awareness

Hospital Measures

Early detection
Quarantine contacts
Strict hygiene protocols

Vaccine Status

No approved vaccine yet
Several vaccines in clinical trials

14. Mortality & Prognosis

Fatality Rate: 40–75%
Worse outcomes with:

* Rapid neurological deterioration

* Respiratory failure

* Delayed hospitalization

15. Global & Indian Context

First outbreak: Malaysia (1998)
Recurrent outbreaks: Bangladesh, India (Kerala)
WHO classifies Nipah virus as a priority pandemic threat

16. Patient Counselling Points

Seek urgent care for fever + confusion
Avoid contact with suspected cases
Follow hygiene & infection prevention
Survivors may need long-term neurological follow-up

17. Key Takeaway Summary

Nipah virus is a highly fatal zoonotic encephalitis virus
Spreads via bats, animals, and human contact
Causes brain inflammation & respiratory failure
No cure yet — prevention & early supportive care save lives